Targeting Genome Stability in Melanoma—A New Approach to an Old Field

por Osrodek, Marta, Wozniak, Michal
Publicado 2021

Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells

por Osrodek, Marta, Rozanski, Michal, Czyz, Malgorzata
Publicado 2020

Physiologically Relevant Oxygen Concentration (6% O(2)) as an Important Component of the Microenvironment Impacting Melanoma Phenotype and Melanoma Response to Targeted Therapeutic...

por Osrodek, Marta, Hartman, Mariusz L., Czyz, Malgorzata
Publicado 2019

17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity and cooperatively induces apoptosis with MEK1/2 and BRAF(V600E) inhibitors in melanoma cells of different g...

por Mielczarek-Lewandowska, Aleksandra, Sztiller-Sikorska, Malgorzata, Osrodek, Marta, Czyz, Malgorzata, Hartman, Mariusz L.
Publicado 2019

Plasticity of Drug-Naïve and Vemurafenib- or Trametinib-Resistant Melanoma Cells in Execution of Differentiation/Pigmentation Program

por Czyz, Malgorzata, Sztiller-Sikorska, Malgorzata, Gajos-Michniewicz, Anna, Osrodek, Marta, Hartman, Mariusz L.
Publicado 2019

Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of (V600E)BRAF melanoma cells and their response to vemurafenib and trametinib in vitro

por Zalesna, Izabela, Osrodek, Marta, Hartman, Mariusz L., Rozanski, Michal, Sztiller-Sikorska, Malgorzata, Niewinna, Karolina, Nejc, Dariusz, Czyz, Malgorzata
Publicado 2017

The lactate-NAD(+) axis activates cancer-associated fibroblasts by downregulating p62

por Linares, Juan F., Cid-Diaz, Tania, Duran, Angeles, Osrodek, Marta, Martinez-Ordoñez, Anxo, Reina-Campos, Miguel, Kuo, Hui-Hsuan, Elemento, Olivier, Martin, M. Laura, Cordes, Thekla, Thompson, Timothy C., Metallo, Christian M., Moscat, Jorge, Diaz-Meco, Maria T.
Publicado 2022